Video Assisted Informed Consent for Lortab to Improve Patient Satisfaction and Knowledge
NCT ID: NCT01374295
Last Updated: 2014-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2011-03-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of a Decision Aid on Patient Decision Making in Emergency Department Chest Pain Patients
NCT01077037
Patient Perception of Video Advance Care Planning
NCT02692950
A Prospective Randomized Trial Using Video Images in Advance Care Planning in Seriously Ill Hospitalized Patients
NCT01325519
Comparing Paper-based and Tablet-delivered Informed Consent for Older Adults
NCT02114970
Virtual cOaching in Making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)
NCT03834870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients who receive Lortab medication or prescription during their ED visit and agree to the study are randomized to receive either standard patient education (from healthcare provider) or watch a 3 minute video. After the medication teaching has been provided the patient is given the medicine and a asked to complete a ten-question survey. This takes approximately five minutes and asks the patient to rate the quality of the information received.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
video
If randomized to this arm patient watches a 3 minute video
video
watch a 3 minute video
standard education
If randomized to this arm patient receives standard verbal education from healthcare provider.
standard education
Receives standard verbal education from healthcare provider
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
video
watch a 3 minute video
standard education
Receives standard verbal education from healthcare provider
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18 year or older
Exclusion Criteria
* age less than 18 years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Albany Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wayne Triner
Professor Dept. of Emergency Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Albany Medical Center
Albany, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Lortab
Identifier Type: -
Identifier Source: secondary_id
2981
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.